SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (DNLI) today reported financial results for the third quarter ended September 30, 2025, and provided business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results